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An ongoing controversy exists on beneficial versus harmful effects
of high beta-carotene (BC) intake, especially for the lung. To
elucidate potential mechanisms, we studied effects of BC on lung
gene expression. We used a beta-carotene 15,15#-monooxygenase 1
(Bcmo1) knockout mouse (Bcmo12/2) model, unable to convert
BC to retinoids, and wild-type mice (Bcmo11/1) mice to dissect
the effects of intact BC from effects of BC metabolites. As
expected, BC supplementation resulted in a higher BC accumu-
lation in lungs of Bcmo12/2mice than in lungs of Bcmo11/1mice.
Whole mouse genome transcriptome analysis on lung tissue re-
vealed that more genes were regulated in Bcmo12/2 mice than
Bcmo11/1 mice upon BC supplementation. Frizzled homolog 6
(Fzd6) and collagen triple helix repeat containing 1 (Cthrc1) were
significantly downregulated (fold changes 22.99 and 22.60, re-
spectively, false discovery rate < 0.05) by BC in Bcmo12/2. More-
over, many olfactory receptors and many members of the
protocadherin family were upregulated. Since both olfactory re-
ceptors and protocadherins have an important function in sensory
nerves and Fzd6 and Cthrc1 are important in stem cell develop-
ment, we hypothesize that BC might have an effect on the highly
innervated pulmonary neuroendocrine cell (PNEC) cluster.
PNECs are highly associated with sensory nerves and are impor-
tant cells in the control of stem cells. A role for BC in the
innervated PNEC cluster might be of particular importance in
smoke-induced carcinogenesis since PNEC-derived lung cancer is
highly associated with tobacco smoke.
Introduction
Beta-carotene (BC) is an orange colored phytochemical present in
dark green vegetables and colored fruits and is widely used as a col-
oring agent. BC can be metabolized into vitamin A and is used in
supplements to correct for vitamin A deficiency. BC is considered to
be a health-promoting agent because of its antioxidant properties,
thereby preventing radical-induced macromolecular damage. Indeed,
many epidemiological studies showed that an increased intake of di-
etary BC, as well as increased BC plasma concentration, is associated
with a decreased risk for cardiovascular diseases and several types of
cancer, including lung cancer (1,2). Because of this, two large-scale
human intervention trials were performed with the intention to de-
crease lung cancer risk by BC supplementation in male smokers
[Alpha-Tocopherol, Beta-Carotene cancer prevention study (ATBC)]
and in male and female smokers or asbestos-exposed subjects
[carotene and retinol efficacy trial (CARET)]. Unexpectedly, both
studies showed an increased lung cancer risk upon BC supplementa-
tion compared with placebo-supplemented subjects (3,4). At the same
time, a study performed mainly in non-smokers showed no effect of
BC on lung cancer risk (5). Together, studies indicate that BC has
health-promoting capacities, but high intakes can also result in ad-
verse health effects such as an increased lung cancer risk in smokers
and asbestos-exposed subjects. The underlying mechanisms for the
adverse effects of BC action are not precisely known, although several
mechanisms have been suggested, e.g. BC or BC metabolites can
become pro-oxidants at high concentrations (6) or in combination
with oxidative stress (7). There is also evidence that BC supplemen-
tation can result in different levels of the bioactive BC metabolites
such as retinoic acid, which is able to bind to retinoic acid receptors
(RARs) and retinoid X receptors (RXRs) to activate these transcrip-
tion factors. Additionally, retinoic acid-induced catabolism can de-
crease RAR and RXR activity, thereby specifically increasing cell
proliferation (8). However, the exact mechanism is unknown mainly
because BC metabolism greatly differs between humans and mam-
malian model organisms such as mice.
In humans, an increased intake of BC results in an increase in plasma
concentrations of BC and its metabolites. Beta-carotene 15,15#-
monooxygenase 1 (Bcmo1) is a key enzyme in BC metabolism that
cleaves BC symmetrically to form two molecules of retinal, which can
be further metabolized into several other downstream BC metabolites
(9). Rodents, which are herbivores and therefore depend on the pro-
duction of vitamin A from pro-vitamin A carotenoids such as BC,
possess a more active Bcmo1 variant than man. Although in humans,
a significant portion of BC is found intact in plasma, rodents cleave
virtually all absorbed BC to facilitate their vitamin A requirements (10).
The aim of our study was to investigate BC-induced gene expres-
sion changes in the lung. Therefore, male Bcmo1þ/þ mice and
Bcmo1/ mice were fed for 14 weeks with a vitamin A sufficient
diet (1500 IU/kg) without (control) or with supplementation of BC
(BC, 150 mg/kg diet) and microarray analysis was performed
(mouse whole genome arrays) on lung complementary RNA (cRNA).
We were mainly interested in effects of BC in the Bcmo1/ mice
since BC is able to accumulate in tissues of these mice (11). To
dissociate effects induced by BC from effects induced by BC metab-
olites, Bcmo1þ/þ mice were taken along.
Materials and methods
Animals and treatment
Twelve male B6129SF1 (Bcmo1þ/þ) and twelve male B6;129S-Bcmo1tm1dnp
(Bcmo1/) mice, described previously by Hessel et al. (11) were used for the
experiment. The mouse experiment was conducted in accordance with the
German animal protection laws by the guidelines of the local veterinary
authorities. During the breeding and weaning periods of the mice, dams were
maintained on KLIBA 3430 chow diet containing 14000 IU vitamin A/kg
(Provima Kliba AG, Kaiseraugst, Switzerland). Five-week-old Bcmo1þ/þ
and Bcmo1/ mice were caged in groups containing two to three siblings
per group and were maintained under environmentally controlled conditions
(temperature 24C, 12 h/12 h light/dark cycle). Mice had ad libitum access to
feed and water. Basic feed consisted of the palletized diet D12450B (Research
Diets, Inc., New Brunswick, NJ) with a fat content of 10%. The diet was
modified to contain 1500 IU vitamin A/kg of diet, which is a vitamin A
Abbreviations: BC, beta-carotene; Bcmo1, beta-carotene 15,15#-monooxyge-
nase 1; Cthrc1, collagen triple helix repeat containing 1; cDNA, complemen-
tary DNA; CARET, carotene and retinol efficacy trial; cRNA, complementary
RNA; Cy3, cyanine 3-cytidine triphosphate; Cy5, cyanine 5-cytidine triphos-
phate; FDR, false discovery rate; Fzd6, frizzled homolog 6; GO, Gene Ontol-
ogy; HPLC, high-performance liquid chromatography; Olfr, olfactory
receptor; PNEC, pulmonary neuroendocrine cell; Q-PCR, real-time quantita-
tive polymerase chain reaction; RAR, retinoic acid receptor; RXR, retinoid X
receptor; SOM, self-organizing map.
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sufficient diet, and the control diet (control) was supplemented with water
soluble vehicle beadlets (DSM Nutritional Products Ltd, Basel, Switzerland)
containing DL-alpha-tocopherol and ascorbyl palmitate as stabilizers, as well as
carriers such as gelatine, corn oil sucrose and starch. The BC diet (BC) was
supplemented with identical water-soluble beadlets containing BC (DSM Nu-
tritional Products Ltd) to generate 150 mg BC/kg diet. Beadlets were added by
the manufacturer before low temperature pelletting. Feed pellets were color
marked and stored at 4C in the dark. After 14 weeks of dietary intervention,
six Bcmo1þ/þ mice on the control diet (Bcmo1þ/þ Co), six Bcmo1þ/þ mice on
the BC diet (Bcmo1þ/þ BC), six Bcmo1/ on the control diet (Bcmo1/ Co)
and six Bcmo1/ on the BC diet (Bcmo1/ BC) were randomly killed during
three subsequent mornings. Blood was collected from the vena cava after
isoflurane and ketamine anesthesia. Blood was coagulated for at least 20
min at room temperature, cooled to 4C and centrifuged. Lung tissue was
removed, rinsed in phosphate buffered saline and snap frozen in liquid nitro-
gen. The lung tissues were stored at 80C.
High-performance liquid chromatography separation of retinoids and
carotenoids
Retinoids and carotenoids were extracted from lung tissues and plasma under
dim red safety light (k  600 nm). Briefly, tissues (20–40 mg) were homog-
enized in 200 ll of 2 M hydroxylamine (pH 6.8) and 200 ll of methanol with
a glass homogenizer. For determination of BC and retinol in serum, 180 ll
serum was added to 200 ll methanol. Then 400 ll acetone was added either to
these plasma or tissue extracts. Extraction of carotenoids and retinoids was
performed with petroleum ether. The extraction was repeated three times, and
the collected organic phases were dried under nitrogen and dissolved in high-
performance liquid chromatography (HPLC) solvent (n-hexane:ethanol,
99.5:0.5). HPLC separation of BC and retinoids and quantification of peak
integrals was performed as described previously (9). Solvents for HPLC and
extraction were purchased in HPLC grade from Merck (Darmstadt, Germany).
Histology of the lung
Small pieces of upper right lung tissue of two randomly selected animals per
group were fixed by immersion in 0.1 M sodium phosphate buffer containing
4% paraformaldehyde (pH 7.4) overnight at 4C, thereafter dehydrated,
cleared and then paraffin embedded. Three micrometers thick sections were
cut and stained with Periodic Acid Schiff and Mayer’s hematoxylin for histo-
logical analysis.
RNA isolation
Left lung lobes were homogenized in liquid nitrogen using a cooled mortar and
pestle. Total RNA was isolated using TRIzol reagent (Invitrogen, Breda, The
Netherlands) followed by purification using RNeasy columns (QIAGEN,
Venlo, The Netherlands) using the instructions of the manufacturer. RNA
concentration and purity were measured using the Nanodrop system (IsoGen
Life Science, Maarssen, The Netherlands). Approximately 30 lg of total RNA
was isolated with A260:A280 ratios .2 and A260:A230 ratios .1.9 for all sam-
ples, indicating good RNA purity. RNA degradation was checked on the
Experion (Bio-Rad, Veenendaal, The Netherlands) using Experion StdSense
chips (Bio-Rad).
Microarray hybridization procedure
The 4  44k Agilent whole mouse genome microarrays (G4122F; Agilent
Technologies, Santa Clara, CA) were used. Preparation of the sample and
the microarray hybridization were carried out according to the manufacturer’s
protocol with a few exceptions as described previously (12,13). In brief, com-
plementary DNA (cDNA) was synthesized from 1 lg lung RNA using the
Agilent Low RNA Input Fluorescent Linear Amplification Kit for each animal
without addition of spikes. Thereafter, samples were split in two equal
amounts, to synthesize cyanine 3-cytidine triphosphate (Cy3) and cyanine
5-cytidine triphosphate (Cy5) labeled cRNA using half the amounts per dye
as indicated by the manufacturer (Agilent Technologies). Labeled cRNA was
purified using RNeasy columns (QIAGEN). Yield, A260/A280 ratio and Cy3 and
Cy5 activity were examined for every sample using the nanodrop. All samples
met the criteria of a cRNA yield higher than 825 ng and a specific activity of at
least 8.0 pmol Cy3 and Cy5. Thousand two hundred nanograms of every Cy3-
labeled cRNA sample was pooled and used as a common reference pool. In-
dividual 825 ng Cy5-labeled cRNA and 825 ng pooled Cy3-labeled cRNAwere
fragmented in 1 fragmentation and 1 blocking agent (Agilent Technolo-
gies) at 60C for 30 min and thereafter mixed with GEx Hybridization Buffer
HI-RPM (Agilent Technologies) and hybridized in a 1:1 ratio at 65C for 17 h
in an Agilent Microarray hybridization Chamber rotating at 4 r.p.m. After
hybridization, slides were washed according to the wash protocol with
Stabilization and Drying solution (Agilent Technologies). Arrays were scanned
with an Agilent scanner with 10% and 100% laser power intensities (Agilent
Technologies).
Data analyses of microarray results
Signal intensities for each spot were quantified using Feature Extraction 9.1
(Agilent Technologies). Median density values and background values of each
spot were extracted for both the experimental samples (Cy5) and the reference
samples (Cy3). Quality control for every microarray was performed visually,
by using Quality control graphs from Feature extraction and M-A plots and
boxplots that were made using limmaGUI in R (Bioconductor) (14). Data were
imported into GeneMaths XT 2.0 (Applied Maths, Sint-Martens-Latem,
Belgium). Spots with a Cy5 and Cy3 signal twice above background were
selected and log transformed. The Cy5 signal was normalized against the
Cy3 intensity as described before (15). Supervised principal component anal-
ysis and self-organizing map (SOM) analysis were performed using
GeneMaths XT. Direct biological interaction analysis was performed using
Gene Ontology (GO) overrepresentation analysis (ErmineJ) (16) and literature
data mining.
Analysis of messenger RNA expression by real-time quantitative polymerase
chain reaction
Differential gene expression of frizzled homolog 6 (Fzd6) and collagen triple
helix repeat containing 1 (Cthrc1) was analyzed using real-time quantitative
polymerase chain reaction (Q-PCR) to validate microarray results. One micro-
gram RNA isolated from lung of individual animals was converted into cDNA
using the iScript cDNA Synthesis Kit (Bio-Rad). One sample was taken along
without reverse transcriptase to examine the presence of DNA (-RT reaction). An
equal amount of cDNA of all individual samples was pooled and diluted (10,
31.6 100, 316 1000, 3160 and 10000) for the generation of a calibra-
tion curve. Each polymerase chain reaction (25 ll) contained 1 iQ SYBR green
supermix (Bio-Rad), 10 lM sense primer, 10 lM antisense primer and 2 ll
100 times diluted cDNA. Primers for Fzd6 were sense 5#-ACTCCCAGCGCCA-
AAGATCG-3# and antisense 5#-GCAGAGATGTGGAGCCCTTGAG-3#; for
Cthrc1, sense 5#-TGGACCAAGGAAGCCCTGAGT-3# and antisense 5#-TG-
AACAGGTGCCGACCCAGA-3; for olfactory receptor 437 (Olfr437), sense
5#-TGGCCTGCGCCGACACTTTG and anti-sense 5#-GGCCTTCCTGCGA-
CCCTCCT and for protocadherin beta 9 (Pcdhb9), sense 5#-TGTTAGTG-
GATGGCTTCT and antisense 5#-ATGACCAGGTACAATGTAAG.
For the amplification of the reference genes, we used for syntaxin 5a (Stx5a),
sense 5#-TTAAAGAACAGGAGGAAACGATTCAGAG-3# and antisense 5#-
CAGGCAAGGAAGACCACAAAGATG-3# and for ring finger protein 130
(Rnf130), sense 5#-ACAGGAACCAGCGTCGTCTTG-3# and antisense 5#-
ACCCGAACAACATCATTCTGCTTATAG-3#, which showed equal gene ex-
pression levels for all individual animals on the microarray. These intron-
spanning primers were designed using Beacon designer 7.00 (Premier Biosoft
International, Palo Alto, CA) or using primer-BLAST (Cthrc1) (http:
//www.ncbi.nlm.nih.gov/). Amplification was performed in duplicate for
Fzd6 and Cthrc1 and in quadruplets for Olfr437 and Pcdhb9 because of the
relatively low absolute expression levels and relatively low fold changes, using
the MyIQ single-color real-time polymerase chain reaction detection system
(Bio-Rad). We used the following temperature cycles: 1 3 min at 95C, 40
two-step amplification [15 s 95C, 45 s 60C (Fzd6, Cthrc1, Stx5a and Rnf130)
or 54C (Olfr437) or 57.5C (Pcdhb9)], 1 1 min 95C and 1 1 min 65C
followed by melting curve analysis (60 10 s 65C with an increase of 0.5C
per 10 s). A negative control without cDNA template and the -RT sample were
taken along with every assay. Using the standard curves for every gene,
the relative level of expression of all genes was calculated. Normalized
Gene Expression (DDCT) analysis for Fzd6 and Cthrc1 was calculated using
the IQ5 software version 2.0 (Bio-Rad).
Statistical analysis
Fold changes for both microarray gene expression and Q-PCR gene expression
were calculated using mean log signal intensities. P-values for differential
expressions were calculated between two groups using Student’s t-test statis-
tics on log intensity values (Excel version 2003). Changes were considered
statistically significant at P , 0.05. To identify ‘marker-regulated genes’ from
other regulated genes, the Benjamini–Hochberg false discovery rate (FDR)
testing method (Genemaths XT) was used to correct for multiple comparisons.
The effects of Diet and Genotype on concentrations of BC, retinol and retinyl
esters in lung and serum were analyzed using 2  2 factorial univariate anal-
ysis of variance (SPSS version 15.0) and considered statistically significant
when P , 0.05. A Student’s t-test was used to test for the effect of a BC diet
versus control diet and considered statistically significant when P , 0.05.
Correlations and differences in correlations between BC concentration and
BC metabolite concentrations in lung were tested (SPSS) and considered sig-
nificant when P , 0.05.
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Results
BC metabolism in Bcmo1þ/þ mice and Bcmo1/ mice
BC supplementation resulted in increased BC concentrations in se-
rum and lung tissue. Bcmo1/ mice accumulated 3.5 times more
BC in serum and 2 times more BC in lung tissue than Bcmo1þ/þ
mice upon BC supplementation. BC supplementation also resulted
in an increased lung retinol and retinyl ester concentration in both
Bcmo1þ/þ mice and Bcmo1/ mice (Figure 1A–E). Correlations
between concentrations of BC with retinol and BC with retinyl esters
in mouse lung were made to investigate a possible dysregulation in
BC metabolite accumulation. BC concentrations correlated signifi-
cantly with retinol (R 5 0.705, P , 0.05) and retinyl ester
(R 5 0.90, P , 0.001) concentrations in lungs of Bcmo1þ/þ mice.
In Bcmo1/, there was also a significant positive correlation
between BC and retinol (R 5 0.74, P , 0.01) or retinyl esters
(R 5 0.89, P , 0.001) in the lung. The slope of the correlation
between BC and retinyl ester concentration in lungs of Bcmo1/
compared with Bcmo1þ/þ mice were significantly different
(P , 0.001), a similar difference in slopes was shown in the corre-
lation between BC and retinol; this was however not significant
(Figure 1F and G).
We also investigated whether gene expression differences were pres-
ent in downstream BC metabolizing enzymes in Bcmo1/ mice as
compared with Bcmo1þ/þ mice and in BC-supplemented mice com-
pared with control diet-fed mice. We found downregulation in gene
expression of alcohol dehydrogenase 7 (class IV), mu or sigma poly-
peptide (Adh7); upregulation in gene expression of aldehyde dehydro-
genase family 1, subfamily A2 (Aldh1a2); upregulation in gene
expression of aldehyde dehydrogenase 2, mitochondrial (Aldh2) and
an upregulation in gene expression of lecithin-retinol acyltransferase
(phosphatidylcholine-retinol-O-acyltransferase) (Lrat) in Bcmo1/
mice (Table I) as compared with Bcmo1þ/þ mice.
These data show that BC accumulation was present in BC-
supplemented Bcmo1/ mice. The tight correlation between retinyl
esters and BC supplementation in both Bcmo1þ/þ mice was still
tightly correlated in Bcmo1/, although the ratio BC:retinyl esters
was much higher in Bcmo1/ mice. Moreover, the knockout of the
Fig. 1. BC and BC metabolite concentrations in lungs of Bcmo1þ/þ and Bcmo1/ mice. BC concentration in serum (A) and lung tissue (B), retinyl ester
concentration in lung tissue (C), retinol concentrations in serum (D) and in lung tissue (E) of male Bcmo1þ/þ mice and Bcmo1/ mice fed a control diet (white
bars) or a BC diet (black bars). Correlation of BC concentration and retinyl ester concentration in lung (F) (Bcmo1þ/þ: R 5 0.90, P , 0.001; Bcmo1/:
R 5 0.89, P , 0.001) with significant different slopes (P , 0.001) for Bcmo1þ/þ (slope 5 311.8) and Bcmo1/ (91.94) and correlation of BC concentration
and retinol concentration in lung (G) (Bcmo1þ/þ: R 5 0.705, P , 0.05; Bcmo1/: R 5 0.746, P , 0.01) with non-significant different slopes measured in
Bcmo1þ/þ mice (closed circles) and Bcmo1/ mice (open circles). Concentrations (A–E) are expressed as mean ± SEM, significance was tested for diet (BC) and
genotype (G) using analysis of variance (ANOVA) and considered significant at P , 0.05. Significant effects for the different factors; diet (BC), genotype (G) or
an interaction (BC  G) are displayed on top of each figure. A Student’s t-test was used between BC and control groups when there was a significant diet effect
using ANOVA and considered significant when P , 0.05. Using t-test statistics: P , 0.05, P , 0.01 and P , 0.001.
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important BC metabolizing enzyme Bcmo1 resulted in a changed gene
expression of other important downstream BC metabolizing enzymes.
BC supplementation downregulates Fzd6 and Cthrc1 gene expression
in Bcmo1/ mice
Histology did not show any obvious differences in lung structure
between mice of the four different groups. We also analyzed gene
expression changes in the lung of Bcmo1þ/þ mice and in Bcmo1/
mice after feeding a BC diet. Supervised principal component analy-
sis showed that mice were clearly separated based on genotype (prin-
cipal component 1) and that Bcmo1/ mice receiving the control
diet were clearly separated from Bcmo1/ mice receiving the
BC-supplemented diet (principal component 2) (Figure 2A).
From the 43379 probe sets (number of spots without control spots)
present on the array, 33414 spots had an intensity of more than twice
above the background. Of these spots, 326 were differentially ex-
pressed (P, 0.05) in Bcmo1þ/þ mice (genes are listed in supplemen-
tary Table I, available at Carcinogenesis Online) and 1474 were
differentially expressed (P , 0.05) in Bcmo1/ mice (genes are
listed in supplementary Table II, available at Carcinogenesis Online)
upon BC supplementation (Figure 2B). Since BC accumulation was
higher in Bcmo1/ mice and more genes were significantly differ-
entially expressed in Bcmo1/ mice, we further focused on effects of
BC in this group.
To identify key BC-regulated genes, FDR testing was performed.
Two genes were downregulated by BC with a FDR , 0.05; Fzd6)
and Cthrc1 with a fold change of 2.99 and 2.60, respectively, in
BC-supplemented Bcmo1/ compared with Bcmo1/ control mice.
These genes had also the lowest P-values in the data set (Figure 2C).
The significant downregulation of Fzd6 and Cthrc1 was confirmed by
Q-PCR (Figure 3A and B). Nutritional intervention studies usually
produce mild transcriptional effects and in many cases, no genes pass
FDR selection (17). Therefore, we consider the BC-induced changes in
Fzd6 and Cthrc1 gene expression as being important and further fo-
cused on these two genes, especially because these two genes may be
involved in the same pathway. The expression of the genes Fzd6 and
Cthrc1 was compared between all four groups; control Bcmo1þ/þ, BC-
supplemented Bcmo1þ/þ, control Bcmo1/ and BC-supplemented
Bcmo1þ/þ to examine if effects were specific for BC supplementation
inBcmo1/mice. Indeed, BC supplementation resulted in a significant
downregulation of Fzd6 and Cthrc1 only in Bcmo1/ mice and not in
Bcmo1þ/þ mice (Figure 3C).
Overrepresented GO processes by BC supplementation in Bcmo1/
SOM analysis is a technique that groups genes with a similar inter-
individual gene expression pattern in the same cluster. The distance
between the clusters in the clustering profile represents the degree of
difference in gene expression patterns (18). We applied SOM analysis
to identify genes regulated with similar interindividual variations in
gene expression as Fzd6 and Cthrc1. The total number of SOM pro-
files was set to 144, corresponding to an average of 10 genes per
profile (12). SOM analysis clustered all genes into only five clusters
from the 144 possible clusters. Moreover, clusters were relatively
close together, which indicates that all regulated genes (P , 0.05)
have a relatively similar variation in gene expression pattern between
animals (Figure 4).
Knowledge is limited concerning the function of Cthrc1 and Fzd6 in
lung. Overrepresented GO processes might result in a hypothesis con-
cerning the function of BC or BC-induced Fzd6 and Cthrc1 regulation
in lung tissue. Since significantly regulated genes had a relative similar
gene expression pattern according to SOM analysis, we performed GO
using the bioinformatics tool ErmineJ, using all genes and their corre-
sponding P-values, and not a subset of genes. The four overrepresented
GO processes with the lowest P-value were as follows: GO:0007608,
sensory perception of smell (P 5 1.89  109); GO:0007606, sen-
sory perception of chemical stimulus (P 5 1.54  108) and
GO:0007156, homophilic cell adhesion (P 5 2.44  1008) (supple-
mentary Table III is available at Carcinogenesis Online). The GO
processes sensory perception of smell and sensory perception of chem-
ical stimulus contained the same different olfactory receptors (Olfr)
(26 differentOlfr andCyclic nucleotide-gated channel alpha 2 (Cnga2)
P , 0.05) (Table II). The GO process homophilic cell adhesion con-
tained mainly different forms of the clustered cadherin family
(nine different Protocadherin beta’s, two Protocadherins, two differ-
ent Cadherins and Desmoglein P , 0.05) (Table II). Q-PCR con-
firmed the upregulation of Olfr437 and Pcdhb9 in Bcmo1/ mice
after BC supplementation (Figure 5A and B). The significantly regu-
lated Olfr and Protocadherins were present in all SOM profiles, which
had relatively similar average gene expression patterns between the
animals.
Discussion
In this study, we assessed effects of BC supplementation in male wild-
type (Bcmo1þ/þ) mice, which are able to metabolize BC to a high extent,
and in male Bcmo1-knockout (Bcmo1/) mice, which are unable to
symmetrically cleave BC. Indeed, the concentration of BC in serum and
lung was increased to a higher level inBcmo1/ mice than inBcmo1þ/þ
mice after BC supplementation. Genome-wide transcriptome analysis
revealed that around two times more genes were regulated in Bcmo1/
mice than in Bcmo1þ/þ mice by BC supplementation. BC supplemen-
tation inBcmo1/ mice resulted in three main, very significant findings.
First, the genes Fzd6 and Cthrc1 were both very significantly down-
regulated (FDR , 0.05) with a fold change of 2.99 and 2.60, re-
spectively. These genes are both involved in the Wnt–Fzd pathway that is
important in the regulation of cell fate determination and development.
Second, many olfactory receptors and members of the clustered proto-
cadherin family were upregulated, and the presence of both groups of
genes is mainly reported in neuronal cells. A third observation was that
the interindividual gene expression patterns between the genes were
highly similar. Pulmonary neuroendocrine cells (PNECs) are highly
associated with sensory nerves and are involved in stem cell
Table I. Genes involved in downstream BC metabolism and retinoic acid catabolism that were regulated by BC supplementation or knockout of Bcmo1
Gene symbol Gene name Sequence ID Probe name Gene expression

Bcmo1þ/þ Bcmo1/
Co BC Co BC
Adh7 alcohol dehydrogenase 7 (class IV), mu or sigma
polyapeptide
NM_009626 A_51_P233797 1.00a 1.01a 1.83b 1.62b
Aldh1a2 aldehyde dehydrogenase family 1, subfamily A2 NM_009022 A_52_P58145 1.00a 1.02a 1.35b 1.32b
Aldh2 aldehyde dehydrogenase 2, mitochondrial AK163452 A_52_P13109 1.00a 1.03a 1.49b 1.49b
Lrat lecithin-retinol acyltransferase (phosphatidylcholine-
retinol-O-acyltransferase)
NM_023624 A_52_P669005 1.00a 1.57b 1.80bc 2.67c

Gene expression relative to Bcmo1þ/þ control mice.
Different letters indicate a significant difference (P , 0.05).
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Fig. 2. Presentation of BC-induced gene expression effects in Bcmo1þ/þ and Bcmo1/ mice. (A) Supervised principal component analysis of Bcmo1þ/þ mice
(circles), Bcmo1/ (squares) receiving a control diet (open symbol) or BC diet (closed symbol). Mice are clearly separated based on genotype (x-axis) and
Bcmo1/ mice receiving the BC diet are clearly separated from Bcmo1/ control mice. (B) Venn diagram representing the number of regulated genes
(P , 0.05) upon BC supplementation in Bcmo1þ/þ mice (left circle) and Bcmo1/ mice (right circle) and the number of overlapping regulated genes in both
groups. (C) Volcano plot representing the effect of BC supplementation on fold change gene expression difference in Bcmo1/ mice compared with the control
diet (x-axis) and the corresponding Student’s t-test P-value on the y-axis. This plot clearly shows a similar low P-value and relatively high absolute fold change for
both Cthrc1 and Fzd6. In gray, are all genes with P . 0.05 and in black, all genes with P , 0.05.
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development during injury and repair. Since the BC-regulated genes are
involved in neuronal and developmental pathways, BC might specifi-
cally affect the highly innervated PNECs. A role for BC in the regulation
of PNECs might be of particular importance in smoke-induced lung
carcinogenesis since PNEC tumors comprise 20% of all lung cancers
and are strongly associated with tobacco use.
Fig. 4. SOM analysis of genes regulated by BC in Bcmo1/ mice (P , 0.05). SOM profile for BC-regulated genes (P , 0.05) in Bcmo1/ mice. SOM analysis
presents all genes with a similar interindividual gene expression within one group. The number of possible SOM profiles was set to 144, corresponding to an
average of 10 genes per profile (12). The average gene expression pattern of every cluster is plotted with corresponding cluster numbers. Average log gene
expression (y-axis) per cluster is plotted per animal (x-axis) with a rank of increasing animal number per group.
Fig. 3. Gene expression of Fzd6 and Cthrc1. The expression of the genes Fzd6 (A) and Cthrc1 (B) in the BC-supplemented mice relative to the control diet-fed
mice were confirmed by Q-PCR using the stable reference genes Stx5a and Rnf130. Data represent the average gene expression ± SEM compared with Bcmo1þ/þ control
mice. P , 0.001 using a Student’s t-test on the log-transformed data. (C) Microarray-based heatmap shows a low interindividual difference between the mice for the
genesCthrc1 andFzd6 and a decreased gene expression of these genes in BC-supplementedBcmo1/ mice compared withBcmo1þ/þmice andBcmo1/ control mice.
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In this study, we found a notable downregulation of Fzd6 and
Cthrc1 by dietary BC in Bcmo1/ mice. Fzd6 encodes a member
of the Frizzled receptor family of transmembrane receptors for Wnt
signals (19) and Cthrc1 encodes a secreted protein (20). Both Fzd6
and Cthrc1 were downregulated to a similar degree and had a similar
FDR suggesting that these genes were jointly regulated. This is in line
with recent findings that Cthrc1 stabilizes the Wnt–Fzd complex (21).
The main known function of Fzd6 that emerges among the relatively
limited number of studies on this protein is its involvement in
patterning during development (22). But the precise functions of
Fzd6 and Cthrc1 are, as yet, unknown for the lung. Fzd6 might have
an important function in the lung since it is highly expressed in adult
and fetal human lung tissue (23).
The highly significant BC-induced downregulation of Fzd6 and
Cthrc1 was observed in combination with an upregulation of many
different olfactory receptors, protocadherins and cadherins in the
Bcmo1/ mice. Clustered protocadherins are highly expressed in
neurons and become highly enriched at synapses during development,
and their expression decreases after neuronal maturation (24). The
main described function of olfactory receptors is that they bind odor-
ant molecules in the olfactory bulb to result in a neuronal signal
transduction through sensory nerves. Although the name ‘olfactory
receptor’ implicates a function only in olfaction, the presence and
a function for olfactory receptors in tissues other than the olfactory
bulb, has been described (25,26). The function for olfactory receptors
in the lung is unknown, but it is tempting to speculate that they might
have a role in sensing the environment. In line with this, similar as in
olfaction, sensory neurons are important in the lung to allow the lung
to detect differences in the environment. The main function of sensory
neurons in the lung is to allow the lung to react to differences in air
composition, such as reduced oxygen tension (hypoxia) (27,28)
or differences in CO2 concentrations (29,30). A possible function
for olfactory receptors in the lung might thus be the detection of
changes in the air composition.
Table II. Genes present (P , 0.05) in the three most significantly BC-regulated GO processes as determined by ErmineJ in lung tissue of Bcmo1/ mice
Gene symbol Gene name Sequence ID Probe name Gene expressiona Gene expressionb
Bcmo1þ/þ Co Bcmo1þ/þ BC Bcmo1/ Co Bcmo1þ/þ BC
GO:0007608 sensory perception of smell and GO:0007606 sensory perception of chemical stimulusc
Olfr945 olfactory receptor 945 NM_146506 A_51_P200249 1.00 1.15 (n.s.) 1.00 1.21 (0.004)
Cnga2 cyclic nucleotide gated
channel alpha 2
NM_007724 A_51_P423948 1.00 1.05 (n.s.) 1.00 1.16 (0.006)
Olfr437 olfactory receptor 437 NM_146296 A_51_P108555 1.00 1.03 (n.s.) 1.00 1.23 (0.011)
Olfr1131 olfactory receptor 1131 NM_146658 A_51_P113058 1.00 1.00 (n.s.) 1.00 1.11 (0.012)
Olfr570 olfactory receptor 570 NM_147110 A_51_P352864 1.00 1.05 (n.s.) 1.00 1.14 (0.013)
Olfr411 olfactory receptor 411 NM_146709 A_51_P191572 1.00 1.01 (n.s.) 1.00 1.17 (0.013)
Olfr1417 olfactory receptor 1417 NM_146936 A_51_P115139 1.00 1.02 (n.s.) 1.00 1.18 (0.014)
Olfr126 olfactory receptor 126 NM_146890 A_51_P149531 1.00 1.03 (n.s.) 1.00 1.23 (0.016)
Olfr973 olfactory receptor 973 NM_146613 A_52_P415047 1.00 1.09 (n.s.) 1.00 1.10 (0.020)
Olfr197 olfactory receptor 197 NM_146484 A_52_P133333 1.00 1.01 (n.s.) 1.00 1.19 (0.021)
Olfr74 olfactory receptor 74 NM_054091 A_51_P123314 1.00 1.04 (n.s.) 1.00 1.14 (0.024)
Olfr569 olfactory receptor 569 NM_147088 A_51_P347206 1.00 1.02 (n.s.) 1.00 1.12 (0.027)
Olfr1342 olfactory receptor 1342 NM_146713 A_51_P373583 1.00 1.07 (n.s.) 1.00 1.15 (0.033)
Olfr159 olfactory receptor 159 NM_019476 A_51_P112682 1.00 1.04 (n.s.) 1.00 1.09 (0.034)
Olfr611 olfactory receptor 611 NM_146727 A_51_P129972 1.00 1.08 (n.s.) 1.00 1.13 (0.034)
Olfr446 olfactory receptor 446 NM_146295 A_51_P514902 1.00 1.05 (n.s.) 1.00 1.16 (0.037)
Olfr1411 olfactory receptor 1411 NM_146490 A_51_P275365 1.00 1.05 (n.s.) 1.00 1.17 (0.039)
Olfr1030 olfactory receptor 1030 NM_146588 A_51_P276149 1.00 1.03 (n.s.) 1.00 1.13 (0.041)
Olfr870 olfactory receptor 870 NM_146904 A_51_P201751 1.00 1.00 (n.s.) 1.00 1.11 (0.042)
Olfr668 olfactory receptor 668 NM_147059 A_51_P515949 1.00 1.03 (n.s.) 1.00 1.09 (0.042)
Olfr397 olfactory receptor 397 NM_146346 A_51_P352636 1.00 1.04 (n.s.) 1.00 1.14 (0.043)
Olfr266 olfactory receptor 266 NM_146489 A_52_P358720 1.00 1.02 (n.s.) 1.00 1.08 (0.044)
Olfr187 olfactory receptor 187 NM_146322 A_51_P386280 1.00 1.01 (n.s.) 1.00 1.16 (0.045)
Olfr469 olfactory receptor 469 NM_146426 A_52_P313007 1.00 1.08 (n.s.) 1.00 1.10 (0.046)
Olfr239 olfactory receptor 239 NM_207175 A_51_P484279 1.00 1.12 (n.s.) 1.00 1.20 (0.047)
Olfr1419 olfactory receptor 1419 NM_001011775 A_52_P232438 1.00 1.07 (n.s.) 1.00 1.16 (0.047)
Olfr740 olfactory receptor 740 NM_146667 A_52_P390844 1.00 1.04 (n.s.) 1.00 1.14 (0.049)
GO:0007156: Homophilic cell adhesion
Pcdhb16 protocadherin beta 16 NM_053141 A_51_P191743 1.00 1.00 (n.s.) 1.00 1.24 (0.000)
Pcdhb9 protocadherin beta 9 NM_053134 A_51_P483878 1.00 1.12 (n.s.) 1.00 1.23 (0.007)
Pcdh12 protocadherin 12 NM_017378 A_52_P515769 1.00 1.01 (n.s.) 1.00 1.26 (0.007)
Pcdhb7 protocadherin beta 7 NM_053132 A_51_P184223 1.00 1.12 (n.s.) 1.00 1.40 (0.007)
Pcdhb18 protocadherin beta 18 NM_053143 A_51_P511918 1.00 1.05 (n.s.) 1.00 1.15 (0.011)
Pcdhb4 protocadherin beta 4 NM_053129 A_52_P529195 1.00 1.09 (n.s.) 1.00 1.72 (0.012)
Pcdhb15 protocadherin beta 15 NM_053140 A_51_P159833 1.00 1.02 (n.s.) 1.00 1.20 (0.014)
Celsr2 cadherin EGF LAG
seven-pass G-type receptor 2
NM_017392 A_52_P350148 1.00 1.10 (n.s.) 1.00 1.12 (0.015)
Pcdhb5 protocadherin beta 5 NM_053130 A_51_P257292 1.00 1.03 (n.s.) 1.00 1.11 (0.017)
Cdh22 cadherin 22 NM_174988 A_51_P373573 1.00 1.09 (n.s.) 1.00 1.18 (0.022)
Pcdh1 protocadherin 1 NM_029357 A_51_P239257 1.00 1.03 (n.s.) 1.00 1.13 (0.030)
Dsg2 desmoglein 2 NM_007883 A_52_P88091 1.00 1.03 (n.s.) 1.00 1.14 (0.031)
Pcdhb6 protocadherin beta 6 NM_053131 A_51_P403413 1.00 1.01 (n.s.) 1.00 1.10 (0.033)
Pcdhb10 protocadherin beta 10 NM_053135 A_51_P289066 1.00 1.05 (n.s.) 1.00 1.13 (0.035)
n.s., non-significant difference (P . 0.05) between BC-supplemented Bcmo1þ/þ mice and control Bcmo1þ/þ mice.
aGene expression relative to average gene expression in Bcmo1þ/þ control mice (P-value).
bGene expression relative to average gene expression in Bcmo1/ control mice (P-value).
cBoth GO processes contain the same genes.
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There is one cell type present in lung tissue that is highly associated
and innervated with sensory nerves (28,31,32) and that has the ability
to react to changes in air composition. These cells are the PNECs and it
has been described that PNECs are able to detect for example hypoxia
by the use of receptors that are highly similar to olfactory receptors
(27,28). PNECs can be present as solitary cells or as clusters called the
neuroepithelial bodies (33). Besides a role for the highly innervated
PNECs in airway chemoreception, it has been shown that the neuro-
epithelial body microenvironment is highly important for lung stem
cell development during injury and repair (34–36). Wnt signaling has
been proposed to be key regulator in stem cell control and develop-
ment (37). This dual function for the innervated PNECs in both che-
modetection and in control of development are in correspondence with
our findings: regulation of Fzd6, Cthrc1 and regulation of olfactory
receptors and protocadherins. However, we cannot conclude that there
is a general increase or decrease in the number of PNECs since Fzd6
and Cthrc1 were downregulated, whereas the olfactory receptors and
the protocadherins were mainly upregulated. We can speculate on this.
It is known that sensory nerves involved in olfaction are generated and
regenerated from neuronal stem cells every 40 days throughout a life-
time (38), but the generation and regeneration of sensory nerves is, as
far as we know, unknown for the lung. Generation and regeneration of
sensory nerves might also be important in the lung and therefore, it is
tempting to assume that there might be an important function of the
stem cell developmental genes Fzd6 and Cthrc1 in sensory neurogen-
esis, resulting in an upregulation of olfactory receptors and protoca-
deherins. The Wnt–Fzd complex can activate the canonical pathway
for cell differentiation or alternatively, signals the non-canonical
pathway for control of cell movement and tissue polarity (39,40).
The non-canonical pathway can be further subdivided into the wnt/
Ca2þ pathway, which is not very well characterized at this moment,
and into the wnt/planar cell polarity pathway that is typically involved
in hair patterning and cell motility by the control of actin polymeri-
zation (41). Although Cthrc1 and Fzd6 are both implicated in the wnt/
planar cell polarity process and the main known function of Fzd6 is the
control of developmental patterning, Fzd6 was also found to suppress
the canonical pathway in Fzd6-transfected cells (21). Indeed, in lung
epithelial cells, an increase in confluence resulted in an increase in
Fzd6 and a decrease in activation of the canonical pathway (42). Our
findings in BC-supplemented animals show the same mechanism but
in the opposite direction; a downregulation of Fzd6 in combination
with an upregulation of olfactory receptors, protocadherins and
cadherins (supplementary Figure 1 is available at Carcinogenesis
Online).
The next question is whether our data might explain —part of— the
mechanism underlying the increased lung cancer risk upon BC sup-
plementation in smokers (ATBC and CARET). Small-cell lung car-
cinoma and the most significant form of large-cell lung carcinoma,
large-cell neuroendocrine lung carcinoma, originate both from
PNECs (43,44). In total, PNECs are present in lung very sparsely
with a frequency of 1 PNEC per 2500 epithelial cells (45) however,
PNEC-derived tumors account for 20% of all lung cancers and is
highly associated with tobacco use (46). In the CARET study, the risk
for large-cell lung carcinoma was significantly increased due to BC
supplementation (4). The control of stem cells is important to avoid
undesired cell growth, which ultimately can result in cancer (47). The
Wnt pathway is one of the most important pathways involved in stem
cell control and a dysregulation of these genes can result in uncon-
trolled growth of lung cancer cells (48,49) and might be one of the
explanations in the involvement of BC in the increased lung cancer
risk in smokers of the ATBC and CARET study.
In our study, BC supplementation to Bcmo1/ mice resulted in
a downregulation of Fzd6 and Cthrc1 in combination with an increase
in the neuronal olfactory receptors and in members of the protocad-
herin family. BC itself was never associated with neuronal cell de-
velopment, although its downstream metabolite, retinoic acid is.
Retinoic acid is a ligand for the RARs and the RXRs. Depletion of
vitamin A, a precursor for retinoic acid, or the knockout of the RAR
and/or RXR receptor results in defects of the nervous system (50),
implicating that retinoic acid is of importance in neurogenesis. More-
over, aldehyde dehydrogenase 1 family, member a3 (Aldh1a3), an
important and rate-limiting enzyme in the synthesis of retinoic acid,
has been shown to be present at high concentrations in the neuro-
epithelium and is therefore an important neuroepithelial marker. Mice
without a functional Aldh1a3 enzyme show morphological defects in
the nasal cavity, the most important site of the generation of olfactory
neurons (51). As can be seen in Table I, we showed that several
enzymes important in downstream BC metabolism were changed in
Bcmo1/ mice compared with Bcmo1þ/þ mice. Although BC was
especially high in the Bcmo1/ mice and BC metabolite concentra-
tions were especially high in the Bcmo1þ/þ mice it is unknown at this
moment whether high BC concentrations or for example alterations in
the availability of retinoic acid caused the effects as we have de-
scribed here for BC supplementation in male Bcmo1/ mice.
Altogether we demonstrated that BC was able to accumulate in lungs
of Bcmo1/ mice, thereby decreasing Fzd6 and Cthrc1 gene expres-
sion with a fold change of 2.99 and 2.60, respectively. Moreover,
many olfactory receptors and many members of the protocadherin
family were upregulated. The interindividual differences in gene ex-
pression of the significantly (P , 0.05) regulated genes was low and
therefore resulted in a high correlation of the expression of the genes as
analyzed by SOM analysis. A specific role for the highly expressed
Fzd6 gene and Cthrc1 in lung tissue has never been described. We
hypothesize that BC decreases the regulation of both Fzd6 and Cthrc1,
which possibly have a joint function and that by the downregulation of
these two genes, olfactory receptors and protocadherins are increased.
These processes might be of importance in smoke- or asbestos-induced
lung carcinogenesis and are possibly affected by BC.
Fig. 5. Validation of microarray results. The expression of the genes Olfr437 (A) and Pcdhb9 (B) in BC-supplemented mice relative to control diet-fed mice
analyzed by microarray analysis and Q-PCR using the stable reference genes Stx5a and Rnf130. Data represent the average gene expression ± SEM compared with
control diet-fed mice. P , 0.05 using a Student’s t-test on the log-transformed data.
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Supplementary material
Supplementary Figure 1 and Tables I–III can be found at http://carcin
.oxfordjournals.org/
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